nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—P-Glycoprotein Inhibitors—Everolimus—kidney cancer	0.538	1	CiPCiCtD
Zonisamide—CA9—kidney cancer	0.129	0.527	CbGaD
Zonisamide—CA2—kidney cancer	0.116	0.473	CbGaD
Zonisamide—CYP3A4—Everolimus—kidney cancer	0.00375	0.26	CbGbCtD
Zonisamide—CYP3A4—Temsirolimus—kidney cancer	0.00253	0.176	CbGbCtD
Zonisamide—CA2—collecting duct of renal tubule—kidney cancer	0.00251	0.106	CbGeAlD
Zonisamide—CYP2C19—Sorafenib—kidney cancer	0.0016	0.111	CbGbCtD
Zonisamide—CYP3A4—Pazopanib—kidney cancer	0.00133	0.0923	CbGbCtD
Zonisamide—CA10—cortex of kidney—kidney cancer	0.00132	0.0556	CbGeAlD
Zonisamide—SCN4B—cardiac atrium—kidney cancer	0.00103	0.0433	CbGeAlD
Zonisamide—CYP2C19—urine—kidney cancer	0.000976	0.0412	CbGeAlD
Zonisamide—CYP3A4—Erlotinib—kidney cancer	0.000949	0.0659	CbGbCtD
Zonisamide—CA11—cortex of kidney—kidney cancer	0.000928	0.0392	CbGeAlD
Zonisamide—CA11—cardiac atrium—kidney cancer	0.000883	0.0373	CbGeAlD
Zonisamide—CYP3A4—Paclitaxel—kidney cancer	0.000869	0.0603	CbGbCtD
Zonisamide—CYP3A4—Sorafenib—kidney cancer	0.000771	0.0536	CbGbCtD
Zonisamide—CYP3A4—Vinblastine—kidney cancer	0.000762	0.0529	CbGbCtD
Zonisamide—CYP3A4—Vincristine—kidney cancer	0.000749	0.052	CbGbCtD
Zonisamide—CA7—renal system—kidney cancer	0.000656	0.0277	CbGeAlD
Zonisamide—CA7—kidney—kidney cancer	0.000634	0.0268	CbGeAlD
Zonisamide—CYP3A4—Sunitinib—kidney cancer	0.000625	0.0434	CbGbCtD
Zonisamide—SCN9A—nephron tubule—kidney cancer	0.000589	0.0248	CbGeAlD
Zonisamide—CYP3A4—urine—kidney cancer	0.000577	0.0243	CbGeAlD
Zonisamide—CA3—cardiac atrium—kidney cancer	0.000539	0.0227	CbGeAlD
Zonisamide—CA14—cardiac atrium—kidney cancer	0.000489	0.0206	CbGeAlD
Zonisamide—SCN4A—renal system—kidney cancer	0.000478	0.0201	CbGeAlD
Zonisamide—CYP3A4—Doxorubicin—kidney cancer	0.000468	0.0325	CbGbCtD
Zonisamide—SCN4A—kidney—kidney cancer	0.000462	0.0195	CbGeAlD
Zonisamide—CACNA1H—gonad—kidney cancer	0.00045	0.019	CbGeAlD
Zonisamide—CA12—renal system—kidney cancer	0.000426	0.018	CbGeAlD
Zonisamide—CA12—kidney—kidney cancer	0.000412	0.0174	CbGeAlD
Zonisamide—SCN2A—cortex of kidney—kidney cancer	0.000398	0.0168	CbGeAlD
Zonisamide—AOX1—nephron tubule—kidney cancer	0.000391	0.0165	CbGeAlD
Zonisamide—SCN3A—renal system—kidney cancer	0.000371	0.0157	CbGeAlD
Zonisamide—SCN3A—kidney—kidney cancer	0.000359	0.0152	CbGeAlD
Zonisamide—AOX1—renal system—kidney cancer	0.000356	0.015	CbGeAlD
Zonisamide—SCN3A—cortex of kidney—kidney cancer	0.00035	0.0148	CbGeAlD
Zonisamide—AOX1—kidney—kidney cancer	0.000344	0.0145	CbGeAlD
Zonisamide—CA5B—gonad—kidney cancer	0.000343	0.0145	CbGeAlD
Zonisamide—CA5B—cardiac atrium—kidney cancer	0.000342	0.0144	CbGeAlD
Zonisamide—CA1—renal system—kidney cancer	0.000338	0.0142	CbGeAlD
Zonisamide—AOX1—cortex of kidney—kidney cancer	0.000335	0.0141	CbGeAlD
Zonisamide—SCN5A—cardiac atrium—kidney cancer	0.000332	0.014	CbGeAlD
Zonisamide—CA1—kidney—kidney cancer	0.000326	0.0138	CbGeAlD
Zonisamide—AOX1—gonad—kidney cancer	0.000319	0.0135	CbGeAlD
Zonisamide—AOX1—cardiac atrium—kidney cancer	0.000318	0.0134	CbGeAlD
Zonisamide—MAOB—nephron tubule—kidney cancer	0.000301	0.0127	CbGeAlD
Zonisamide—CA4—nephron tubule—kidney cancer	0.00029	0.0122	CbGeAlD
Zonisamide—MAOB—renal system—kidney cancer	0.000274	0.0116	CbGeAlD
Zonisamide—MAOB—kidney—kidney cancer	0.000265	0.0112	CbGeAlD
Zonisamide—CA4—renal system—kidney cancer	0.000264	0.0111	CbGeAlD
Zonisamide—MAOB—cortex of kidney—kidney cancer	0.000258	0.0109	CbGeAlD
Zonisamide—MAOA—nephron tubule—kidney cancer	0.000257	0.0108	CbGeAlD
Zonisamide—CA4—kidney—kidney cancer	0.000255	0.0108	CbGeAlD
Zonisamide—CA4—cortex of kidney—kidney cancer	0.000248	0.0105	CbGeAlD
Zonisamide—MAOB—cardiac atrium—kidney cancer	0.000245	0.0104	CbGeAlD
Zonisamide—CA2—nephron tubule—kidney cancer	0.000241	0.0102	CbGeAlD
Zonisamide—CA4—cardiac atrium—kidney cancer	0.000236	0.00997	CbGeAlD
Zonisamide—MAOA—renal system—kidney cancer	0.000234	0.00986	CbGeAlD
Zonisamide—MAOA—kidney—kidney cancer	0.000226	0.00953	CbGeAlD
Zonisamide—MAOA—cortex of kidney—kidney cancer	0.00022	0.00928	CbGeAlD
Zonisamide—CA2—renal system—kidney cancer	0.000219	0.00923	CbGeAlD
Zonisamide—CA2—kidney—kidney cancer	0.000212	0.00892	CbGeAlD
Zonisamide—MAOA—cardiac atrium—kidney cancer	0.000209	0.00883	CbGeAlD
Zonisamide—CA2—cortex of kidney—kidney cancer	0.000206	0.00869	CbGeAlD
Zonisamide—CA2—cardiac atrium—kidney cancer	0.000196	0.00827	CbGeAlD
Zonisamide—CYP3A4—renal system—kidney cancer	0.000141	0.00595	CbGeAlD
Zonisamide—CYP3A4—kidney—kidney cancer	0.000136	0.00576	CbGeAlD
Zonisamide—Hypersensitivity—Dactinomycin—kidney cancer	3.61e-05	0.000372	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	3.6e-05	0.000371	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	3.59e-05	0.000369	CcSEcCtD
Zonisamide—Discomfort—Paclitaxel—kidney cancer	3.58e-05	0.000369	CcSEcCtD
Zonisamide—Fatigue—Gemcitabine—kidney cancer	3.58e-05	0.000369	CcSEcCtD
Zonisamide—Gastrointestinal pain—Vincristine—kidney cancer	3.58e-05	0.000369	CcSEcCtD
Zonisamide—Dizziness—Sorafenib—kidney cancer	3.56e-05	0.000366	CcSEcCtD
Zonisamide—Constipation—Gemcitabine—kidney cancer	3.55e-05	0.000366	CcSEcCtD
Zonisamide—Nausea—Erlotinib—kidney cancer	3.55e-05	0.000366	CcSEcCtD
Zonisamide—Alopecia—Capecitabine—kidney cancer	3.55e-05	0.000365	CcSEcCtD
Zonisamide—Dry mouth—Paclitaxel—kidney cancer	3.55e-05	0.000365	CcSEcCtD
Zonisamide—Mood swings—Doxorubicin—kidney cancer	3.55e-05	0.000365	CcSEcCtD
Zonisamide—Diarrhoea—Sunitinib—kidney cancer	3.54e-05	0.000365	CcSEcCtD
Zonisamide—Ataxia—Doxorubicin—kidney cancer	3.52e-05	0.000362	CcSEcCtD
Zonisamide—Mental disorder—Capecitabine—kidney cancer	3.52e-05	0.000362	CcSEcCtD
Zonisamide—Asthenia—Dactinomycin—kidney cancer	3.52e-05	0.000362	CcSEcCtD
Zonisamide—Confusional state—Paclitaxel—kidney cancer	3.51e-05	0.000361	CcSEcCtD
Zonisamide—Blood creatinine increased—Doxorubicin—kidney cancer	3.51e-05	0.000361	CcSEcCtD
Zonisamide—Malnutrition—Capecitabine—kidney cancer	3.5e-05	0.00036	CcSEcCtD
Zonisamide—Dehydration—Doxorubicin—kidney cancer	3.48e-05	0.000358	CcSEcCtD
Zonisamide—Oedema—Paclitaxel—kidney cancer	3.48e-05	0.000358	CcSEcCtD
Zonisamide—Abdominal pain—Vincristine—kidney cancer	3.46e-05	0.000356	CcSEcCtD
Zonisamide—Body temperature increased—Vincristine—kidney cancer	3.46e-05	0.000356	CcSEcCtD
Zonisamide—Liver function test abnormal—Doxorubicin—kidney cancer	3.46e-05	0.000356	CcSEcCtD
Zonisamide—Infection—Paclitaxel—kidney cancer	3.46e-05	0.000356	CcSEcCtD
Zonisamide—Flatulence—Capecitabine—kidney cancer	3.45e-05	0.000355	CcSEcCtD
Zonisamide—Dry skin—Doxorubicin—kidney cancer	3.43e-05	0.000353	CcSEcCtD
Zonisamide—Dysgeusia—Capecitabine—kidney cancer	3.42e-05	0.000352	CcSEcCtD
Zonisamide—Dizziness—Sunitinib—kidney cancer	3.42e-05	0.000352	CcSEcCtD
Zonisamide—Feeling abnormal—Gemcitabine—kidney cancer	3.42e-05	0.000352	CcSEcCtD
Zonisamide—Shock—Paclitaxel—kidney cancer	3.42e-05	0.000352	CcSEcCtD
Zonisamide—Vomiting—Sorafenib—kidney cancer	3.42e-05	0.000352	CcSEcCtD
Zonisamide—Nervous system disorder—Paclitaxel—kidney cancer	3.41e-05	0.000351	CcSEcCtD
Zonisamide—Hypokalaemia—Doxorubicin—kidney cancer	3.41e-05	0.000351	CcSEcCtD
Zonisamide—Thrombocytopenia—Paclitaxel—kidney cancer	3.41e-05	0.000351	CcSEcCtD
Zonisamide—Tachycardia—Paclitaxel—kidney cancer	3.39e-05	0.000349	CcSEcCtD
Zonisamide—Rash—Sorafenib—kidney cancer	3.39e-05	0.000349	CcSEcCtD
Zonisamide—Dermatitis—Sorafenib—kidney cancer	3.39e-05	0.000349	CcSEcCtD
Zonisamide—Skin disorder—Paclitaxel—kidney cancer	3.38e-05	0.000348	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	3.37e-05	0.000347	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	3.37e-05	0.000347	CcSEcCtD
Zonisamide—Headache—Sorafenib—kidney cancer	3.37e-05	0.000347	CcSEcCtD
Zonisamide—Muscle spasms—Capecitabine—kidney cancer	3.36e-05	0.000346	CcSEcCtD
Zonisamide—Hyperhidrosis—Paclitaxel—kidney cancer	3.36e-05	0.000346	CcSEcCtD
Zonisamide—Diarrhoea—Dactinomycin—kidney cancer	3.35e-05	0.000345	CcSEcCtD
Zonisamide—Anorexia—Paclitaxel—kidney cancer	3.32e-05	0.000341	CcSEcCtD
Zonisamide—Gastritis—Doxorubicin—kidney cancer	3.31e-05	0.000341	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	3.3e-05	0.00034	CcSEcCtD
Zonisamide—Muscular weakness—Doxorubicin—kidney cancer	3.3e-05	0.00034	CcSEcCtD
Zonisamide—Vomiting—Sunitinib—kidney cancer	3.29e-05	0.000339	CcSEcCtD
Zonisamide—Body temperature increased—Gemcitabine—kidney cancer	3.28e-05	0.000338	CcSEcCtD
Zonisamide—Tremor—Capecitabine—kidney cancer	3.28e-05	0.000337	CcSEcCtD
Zonisamide—Rash—Sunitinib—kidney cancer	3.26e-05	0.000336	CcSEcCtD
Zonisamide—Dermatitis—Sunitinib—kidney cancer	3.26e-05	0.000336	CcSEcCtD
Zonisamide—Hypotension—Paclitaxel—kidney cancer	3.25e-05	0.000335	CcSEcCtD
Zonisamide—Ill-defined disorder—Capecitabine—kidney cancer	3.24e-05	0.000334	CcSEcCtD
Zonisamide—Headache—Sunitinib—kidney cancer	3.24e-05	0.000334	CcSEcCtD
Zonisamide—Dysphagia—Doxorubicin—kidney cancer	3.24e-05	0.000333	CcSEcCtD
Zonisamide—Influenza—Doxorubicin—kidney cancer	3.24e-05	0.000333	CcSEcCtD
Zonisamide—Anaemia—Capecitabine—kidney cancer	3.23e-05	0.000333	CcSEcCtD
Zonisamide—Hypersensitivity—Vincristine—kidney cancer	3.23e-05	0.000332	CcSEcCtD
Zonisamide—Eosinophilia—Doxorubicin—kidney cancer	3.2e-05	0.00033	CcSEcCtD
Zonisamide—Nausea—Sorafenib—kidney cancer	3.2e-05	0.000329	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—kidney cancer	3.17e-05	0.000326	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.17e-05	0.000326	CcSEcCtD
Zonisamide—Malaise—Capecitabine—kidney cancer	3.15e-05	0.000325	CcSEcCtD
Zonisamide—Insomnia—Paclitaxel—kidney cancer	3.15e-05	0.000324	CcSEcCtD
Zonisamide—Vertigo—Capecitabine—kidney cancer	3.14e-05	0.000323	CcSEcCtD
Zonisamide—Asthenia—Vincristine—kidney cancer	3.14e-05	0.000323	CcSEcCtD
Zonisamide—Syncope—Capecitabine—kidney cancer	3.14e-05	0.000323	CcSEcCtD
Zonisamide—Leukopenia—Capecitabine—kidney cancer	3.13e-05	0.000322	CcSEcCtD
Zonisamide—Paraesthesia—Paclitaxel—kidney cancer	3.12e-05	0.000321	CcSEcCtD
Zonisamide—Vomiting—Dactinomycin—kidney cancer	3.12e-05	0.000321	CcSEcCtD
Zonisamide—Dyspnoea—Paclitaxel—kidney cancer	3.1e-05	0.000319	CcSEcCtD
Zonisamide—Somnolence—Paclitaxel—kidney cancer	3.09e-05	0.000318	CcSEcCtD
Zonisamide—Palpitations—Capecitabine—kidney cancer	3.09e-05	0.000318	CcSEcCtD
Zonisamide—Rash—Dactinomycin—kidney cancer	3.09e-05	0.000318	CcSEcCtD
Zonisamide—Nausea—Sunitinib—kidney cancer	3.08e-05	0.000317	CcSEcCtD
Zonisamide—Loss of consciousness—Capecitabine—kidney cancer	3.07e-05	0.000316	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—kidney cancer	3.07e-05	0.000316	CcSEcCtD
Zonisamide—Dyspepsia—Paclitaxel—kidney cancer	3.06e-05	0.000315	CcSEcCtD
Zonisamide—Cough—Capecitabine—kidney cancer	3.05e-05	0.000314	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—kidney cancer	3.03e-05	0.000311	CcSEcCtD
Zonisamide—Decreased appetite—Paclitaxel—kidney cancer	3.02e-05	0.000311	CcSEcCtD
Zonisamide—Hypertension—Capecitabine—kidney cancer	3.02e-05	0.000311	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	3e-05	0.000309	CcSEcCtD
Zonisamide—Fatigue—Paclitaxel—kidney cancer	3e-05	0.000309	CcSEcCtD
Zonisamide—Diarrhoea—Vincristine—kidney cancer	3e-05	0.000308	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—kidney cancer	2.99e-05	0.000308	CcSEcCtD
Zonisamide—Asthenia—Gemcitabine—kidney cancer	2.98e-05	0.000307	CcSEcCtD
Zonisamide—Arthralgia—Capecitabine—kidney cancer	2.98e-05	0.000306	CcSEcCtD
Zonisamide—Myalgia—Capecitabine—kidney cancer	2.98e-05	0.000306	CcSEcCtD
Zonisamide—Chest pain—Capecitabine—kidney cancer	2.98e-05	0.000306	CcSEcCtD
Zonisamide—Constipation—Paclitaxel—kidney cancer	2.97e-05	0.000306	CcSEcCtD
Zonisamide—Anxiety—Capecitabine—kidney cancer	2.97e-05	0.000305	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.96e-05	0.000304	CcSEcCtD
Zonisamide—Weight increased—Doxorubicin—kidney cancer	2.94e-05	0.000303	CcSEcCtD
Zonisamide—Discomfort—Capecitabine—kidney cancer	2.94e-05	0.000303	CcSEcCtD
Zonisamide—Pruritus—Gemcitabine—kidney cancer	2.94e-05	0.000303	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—kidney cancer	2.93e-05	0.000301	CcSEcCtD
Zonisamide—Dry mouth—Capecitabine—kidney cancer	2.91e-05	0.0003	CcSEcCtD
Zonisamide—Nausea—Dactinomycin—kidney cancer	2.91e-05	0.0003	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—kidney cancer	2.9e-05	0.000299	CcSEcCtD
Zonisamide—Dizziness—Vincristine—kidney cancer	2.9e-05	0.000298	CcSEcCtD
Zonisamide—Confusional state—Capecitabine—kidney cancer	2.88e-05	0.000296	CcSEcCtD
Zonisamide—Feeling abnormal—Paclitaxel—kidney cancer	2.87e-05	0.000295	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.86e-05	0.000294	CcSEcCtD
Zonisamide—Oedema—Capecitabine—kidney cancer	2.85e-05	0.000294	CcSEcCtD
Zonisamide—Gastrointestinal pain—Paclitaxel—kidney cancer	2.84e-05	0.000293	CcSEcCtD
Zonisamide—Diarrhoea—Gemcitabine—kidney cancer	2.84e-05	0.000293	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—kidney cancer	2.84e-05	0.000292	CcSEcCtD
Zonisamide—Infection—Capecitabine—kidney cancer	2.84e-05	0.000292	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—kidney cancer	2.83e-05	0.000291	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—kidney cancer	2.81e-05	0.000289	CcSEcCtD
Zonisamide—Shock—Capecitabine—kidney cancer	2.81e-05	0.000289	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—kidney cancer	2.8e-05	0.000289	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—kidney cancer	2.8e-05	0.000289	CcSEcCtD
Zonisamide—Nervous system disorder—Capecitabine—kidney cancer	2.8e-05	0.000288	CcSEcCtD
Zonisamide—Thrombocytopenia—Capecitabine—kidney cancer	2.79e-05	0.000288	CcSEcCtD
Zonisamide—Tachycardia—Capecitabine—kidney cancer	2.79e-05	0.000287	CcSEcCtD
Zonisamide—Vomiting—Vincristine—kidney cancer	2.78e-05	0.000287	CcSEcCtD
Zonisamide—Skin disorder—Capecitabine—kidney cancer	2.77e-05	0.000285	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—kidney cancer	2.77e-05	0.000285	CcSEcCtD
Zonisamide—Urticaria—Paclitaxel—kidney cancer	2.76e-05	0.000284	CcSEcCtD
Zonisamide—Rash—Vincristine—kidney cancer	2.76e-05	0.000284	CcSEcCtD
Zonisamide—Hyperhidrosis—Capecitabine—kidney cancer	2.76e-05	0.000284	CcSEcCtD
Zonisamide—Dermatitis—Vincristine—kidney cancer	2.76e-05	0.000284	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—kidney cancer	2.75e-05	0.000283	CcSEcCtD
Zonisamide—Abdominal pain—Paclitaxel—kidney cancer	2.75e-05	0.000283	CcSEcCtD
Zonisamide—Body temperature increased—Paclitaxel—kidney cancer	2.75e-05	0.000283	CcSEcCtD
Zonisamide—Headache—Vincristine—kidney cancer	2.74e-05	0.000282	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—kidney cancer	2.73e-05	0.000281	CcSEcCtD
Zonisamide—Anorexia—Capecitabine—kidney cancer	2.72e-05	0.00028	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—kidney cancer	2.69e-05	0.000277	CcSEcCtD
Zonisamide—Hypotension—Capecitabine—kidney cancer	2.67e-05	0.000275	CcSEcCtD
Zonisamide—Vomiting—Gemcitabine—kidney cancer	2.64e-05	0.000272	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—kidney cancer	2.64e-05	0.000271	CcSEcCtD
Zonisamide—Rash—Gemcitabine—kidney cancer	2.62e-05	0.00027	CcSEcCtD
Zonisamide—Dermatitis—Gemcitabine—kidney cancer	2.62e-05	0.000269	CcSEcCtD
Zonisamide—Headache—Gemcitabine—kidney cancer	2.6e-05	0.000268	CcSEcCtD
Zonisamide—Nausea—Vincristine—kidney cancer	2.6e-05	0.000268	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.6e-05	0.000268	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—kidney cancer	2.6e-05	0.000267	CcSEcCtD
Zonisamide—Insomnia—Capecitabine—kidney cancer	2.58e-05	0.000266	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—kidney cancer	2.57e-05	0.000265	CcSEcCtD
Zonisamide—Paraesthesia—Capecitabine—kidney cancer	2.56e-05	0.000264	CcSEcCtD
Zonisamide—Hypersensitivity—Paclitaxel—kidney cancer	2.56e-05	0.000264	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—kidney cancer	2.56e-05	0.000263	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—kidney cancer	2.55e-05	0.000263	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—kidney cancer	2.54e-05	0.000262	CcSEcCtD
Zonisamide—Dyspnoea—Capecitabine—kidney cancer	2.54e-05	0.000262	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—kidney cancer	2.54e-05	0.000261	CcSEcCtD
Zonisamide—Dyspepsia—Capecitabine—kidney cancer	2.51e-05	0.000259	CcSEcCtD
Zonisamide—Asthenia—Paclitaxel—kidney cancer	2.5e-05	0.000257	CcSEcCtD
Zonisamide—Decreased appetite—Capecitabine—kidney cancer	2.48e-05	0.000255	CcSEcCtD
Zonisamide—Nausea—Gemcitabine—kidney cancer	2.47e-05	0.000254	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Capecitabine—kidney cancer	2.46e-05	0.000254	CcSEcCtD
Zonisamide—Fatigue—Capecitabine—kidney cancer	2.46e-05	0.000253	CcSEcCtD
Zonisamide—Pruritus—Paclitaxel—kidney cancer	2.46e-05	0.000253	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—kidney cancer	2.45e-05	0.000252	CcSEcCtD
Zonisamide—Constipation—Capecitabine—kidney cancer	2.44e-05	0.000251	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—kidney cancer	2.42e-05	0.000249	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—kidney cancer	2.41e-05	0.000249	CcSEcCtD
Zonisamide—Diarrhoea—Paclitaxel—kidney cancer	2.38e-05	0.000245	CcSEcCtD
Zonisamide—Feeling abnormal—Capecitabine—kidney cancer	2.35e-05	0.000242	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—kidney cancer	2.34e-05	0.000241	CcSEcCtD
Zonisamide—Gastrointestinal pain—Capecitabine—kidney cancer	2.33e-05	0.00024	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—kidney cancer	2.33e-05	0.00024	CcSEcCtD
Zonisamide—Dizziness—Paclitaxel—kidney cancer	2.3e-05	0.000237	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—kidney cancer	2.29e-05	0.000236	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—kidney cancer	2.27e-05	0.000234	CcSEcCtD
Zonisamide—Urticaria—Capecitabine—kidney cancer	2.27e-05	0.000233	CcSEcCtD
Zonisamide—Abdominal pain—Capecitabine—kidney cancer	2.26e-05	0.000232	CcSEcCtD
Zonisamide—Body temperature increased—Capecitabine—kidney cancer	2.26e-05	0.000232	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—kidney cancer	2.25e-05	0.000232	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—kidney cancer	2.22e-05	0.000229	CcSEcCtD
Zonisamide—Tension—Doxorubicin—kidney cancer	2.21e-05	0.000228	CcSEcCtD
Zonisamide—Vomiting—Paclitaxel—kidney cancer	2.21e-05	0.000228	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—kidney cancer	2.21e-05	0.000227	CcSEcCtD
Zonisamide—Rash—Paclitaxel—kidney cancer	2.19e-05	0.000226	CcSEcCtD
Zonisamide—Dermatitis—Paclitaxel—kidney cancer	2.19e-05	0.000226	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—kidney cancer	2.19e-05	0.000225	CcSEcCtD
Zonisamide—Headache—Paclitaxel—kidney cancer	2.18e-05	0.000224	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—kidney cancer	2.17e-05	0.000223	CcSEcCtD
Zonisamide—Hypersensitivity—Capecitabine—kidney cancer	2.1e-05	0.000216	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—kidney cancer	2.09e-05	0.000215	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—kidney cancer	2.08e-05	0.000214	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—kidney cancer	2.07e-05	0.000213	CcSEcCtD
Zonisamide—Nausea—Paclitaxel—kidney cancer	2.07e-05	0.000213	CcSEcCtD
Zonisamide—Asthenia—Capecitabine—kidney cancer	2.05e-05	0.000211	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—kidney cancer	2.03e-05	0.000209	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—kidney cancer	2.03e-05	0.000208	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—kidney cancer	2.02e-05	0.000208	CcSEcCtD
Zonisamide—Pruritus—Capecitabine—kidney cancer	2.02e-05	0.000208	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—kidney cancer	2.02e-05	0.000208	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—kidney cancer	1.99e-05	0.000205	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—kidney cancer	1.98e-05	0.000204	CcSEcCtD
Zonisamide—Cough—Doxorubicin—kidney cancer	1.97e-05	0.000202	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—kidney cancer	1.95e-05	0.000201	CcSEcCtD
Zonisamide—Diarrhoea—Capecitabine—kidney cancer	1.95e-05	0.000201	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—kidney cancer	1.95e-05	0.0002	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—kidney cancer	1.92e-05	0.000198	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—kidney cancer	1.92e-05	0.000198	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—kidney cancer	1.92e-05	0.000198	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—kidney cancer	1.91e-05	0.000197	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.91e-05	0.000196	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—kidney cancer	1.9e-05	0.000195	CcSEcCtD
Zonisamide—Dizziness—Capecitabine—kidney cancer	1.89e-05	0.000194	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—kidney cancer	1.88e-05	0.000193	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—kidney cancer	1.86e-05	0.000191	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—kidney cancer	1.84e-05	0.000189	CcSEcCtD
Zonisamide—Infection—Doxorubicin—kidney cancer	1.83e-05	0.000188	CcSEcCtD
Zonisamide—Vomiting—Capecitabine—kidney cancer	1.81e-05	0.000187	CcSEcCtD
Zonisamide—Shock—Doxorubicin—kidney cancer	1.81e-05	0.000186	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—kidney cancer	1.8e-05	0.000186	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—kidney cancer	1.8e-05	0.000185	CcSEcCtD
Zonisamide—Rash—Capecitabine—kidney cancer	1.8e-05	0.000185	CcSEcCtD
Zonisamide—Dermatitis—Capecitabine—kidney cancer	1.8e-05	0.000185	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—kidney cancer	1.8e-05	0.000185	CcSEcCtD
Zonisamide—Headache—Capecitabine—kidney cancer	1.79e-05	0.000184	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—kidney cancer	1.79e-05	0.000184	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—kidney cancer	1.78e-05	0.000183	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—kidney cancer	1.75e-05	0.000181	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—kidney cancer	1.72e-05	0.000177	CcSEcCtD
Zonisamide—Nausea—Capecitabine—kidney cancer	1.7e-05	0.000174	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.68e-05	0.000173	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—kidney cancer	1.66e-05	0.000171	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—kidney cancer	1.65e-05	0.00017	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—kidney cancer	1.64e-05	0.000169	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—kidney cancer	1.64e-05	0.000168	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—kidney cancer	1.62e-05	0.000167	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—kidney cancer	1.6e-05	0.000165	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.59e-05	0.000163	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—kidney cancer	1.59e-05	0.000163	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—kidney cancer	1.57e-05	0.000162	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—kidney cancer	1.52e-05	0.000156	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—kidney cancer	1.5e-05	0.000155	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—kidney cancer	1.46e-05	0.00015	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—kidney cancer	1.45e-05	0.00015	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—kidney cancer	1.45e-05	0.00015	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—kidney cancer	1.36e-05	0.00014	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—kidney cancer	1.32e-05	0.000136	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—kidney cancer	1.3e-05	0.000134	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—kidney cancer	1.26e-05	0.00013	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—kidney cancer	1.22e-05	0.000125	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—kidney cancer	1.17e-05	0.00012	CcSEcCtD
Zonisamide—Rash—Doxorubicin—kidney cancer	1.16e-05	0.000119	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—kidney cancer	1.16e-05	0.000119	CcSEcCtD
Zonisamide—Headache—Doxorubicin—kidney cancer	1.15e-05	0.000119	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—kidney cancer	1.09e-05	0.000112	CcSEcCtD
Zonisamide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	5.57e-06	6.89e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PSMD7—kidney cancer	5.55e-06	6.86e-05	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MAPK3—kidney cancer	5.49e-06	6.79e-05	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—kidney cancer	5.45e-06	6.74e-05	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTEN—kidney cancer	5.4e-06	6.68e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN2B—kidney cancer	5.4e-06	6.68e-05	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MAPK1—kidney cancer	5.39e-06	6.67e-05	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MAPK3—kidney cancer	5.39e-06	6.67e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SCARB1—kidney cancer	5.38e-06	6.66e-05	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—kidney cancer	5.35e-06	6.62e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS1—kidney cancer	5.33e-06	6.6e-05	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—RAF1—kidney cancer	5.26e-06	6.51e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—BCHE—kidney cancer	5.26e-06	6.51e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ACY1—kidney cancer	5.25e-06	6.49e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—kidney cancer	5.23e-06	6.48e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—kidney cancer	5.23e-06	6.48e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PSMD7—kidney cancer	5.23e-06	6.47e-05	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—MAPK1—kidney cancer	5.22e-06	6.46e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SLC5A5—kidney cancer	5.19e-06	6.43e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTP1—kidney cancer	5.18e-06	6.41e-05	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MAPK3—kidney cancer	5.15e-06	6.38e-05	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—MAPK1—kidney cancer	5.13e-06	6.34e-05	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—KRAS—kidney cancer	5.09e-06	6.3e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—kidney cancer	5.05e-06	6.25e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.03e-06	6.23e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SLC2A1—kidney cancer	5.01e-06	6.21e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—POMC—kidney cancer	5e-06	6.19e-05	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—kidney cancer	4.97e-06	6.15e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTP1—kidney cancer	4.96e-06	6.14e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—BCHE—kidney cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MAPK3—kidney cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK3—kidney cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CA9—kidney cancer	4.95e-06	6.13e-05	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KRAS—kidney cancer	4.93e-06	6.1e-05	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MAPK1—kidney cancer	4.9e-06	6.07e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ABCB1—kidney cancer	4.9e-06	6.06e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC5A5—kidney cancer	4.89e-06	6.06e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—POMC—kidney cancer	4.87e-06	6.03e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—POMC—kidney cancer	4.87e-06	6.03e-05	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KRAS—kidney cancer	4.84e-06	5.99e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK3—kidney cancer	4.77e-06	5.91e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTP1—kidney cancer	4.76e-06	5.89e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GSTM1—kidney cancer	4.76e-06	5.89e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC2A1—kidney cancer	4.73e-06	5.85e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK1—kidney cancer	4.71e-06	5.83e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MAPK1—kidney cancer	4.71e-06	5.83e-05	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.71e-06	5.83e-05	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK3—kidney cancer	4.7e-06	5.82e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ABCB1—kidney cancer	4.7e-06	5.81e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTP1—kidney cancer	4.67e-06	5.77e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RAF1—kidney cancer	4.66e-06	5.76e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RELA—kidney cancer	4.64e-06	5.74e-05	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—kidney cancer	4.63e-06	5.73e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—kidney cancer	4.61e-06	5.7e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GSTM1—kidney cancer	4.56e-06	5.64e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—POMC—kidney cancer	4.55e-06	5.63e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—POMC—kidney cancer	4.55e-06	5.63e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK1—kidney cancer	4.54e-06	5.62e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP1A1—kidney cancer	4.51e-06	5.58e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ABCB1—kidney cancer	4.5e-06	5.57e-05	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK1—kidney cancer	4.48e-06	5.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.47e-06	5.54e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PDHB—kidney cancer	4.46e-06	5.52e-05	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—kidney cancer	4.45e-06	5.51e-05	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—kidney cancer	4.45e-06	5.51e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—POMC—kidney cancer	4.45e-06	5.5e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ABCB1—kidney cancer	4.42e-06	5.47e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GSTM1—kidney cancer	4.37e-06	5.41e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP1A1—kidney cancer	4.32e-06	5.35e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HIF1A—kidney cancer	4.32e-06	5.34e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—TSC2—kidney cancer	4.3e-06	5.33e-05	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—kidney cancer	4.29e-06	5.31e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GSTM1—kidney cancer	4.29e-06	5.31e-05	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—kidney cancer	4.23e-06	5.23e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—POMC—kidney cancer	4.22e-06	5.22e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CRABP1—kidney cancer	4.21e-06	5.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CCBL1—kidney cancer	4.19e-06	5.19e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTP1—kidney cancer	4.18e-06	5.18e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP1A1—kidney cancer	4.14e-06	5.13e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.12e-06	5.1e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP1A1—kidney cancer	4.06e-06	5.03e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.06e-06	5.03e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CTNNB1—kidney cancer	4.03e-06	4.99e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—kidney cancer	3.99e-06	4.94e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ABCB1—kidney cancer	3.96e-06	4.9e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTP1—kidney cancer	3.94e-06	4.88e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ITPR2—kidney cancer	3.91e-06	4.84e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—kidney cancer	3.89e-06	4.81e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—kidney cancer	3.89e-06	4.81e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GSTM1—kidney cancer	3.84e-06	4.76e-05	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3CA—kidney cancer	3.81e-06	4.71e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—APC—kidney cancer	3.8e-06	4.7e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KIT—kidney cancer	3.8e-06	4.7e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.79e-06	4.69e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.78e-06	4.68e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ABCB1—kidney cancer	3.73e-06	4.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.73e-06	4.62e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1A1—kidney cancer	3.64e-06	4.51e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPAT—kidney cancer	3.64e-06	4.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GLIPR1—kidney cancer	3.64e-06	4.5e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—kidney cancer	3.63e-06	4.49e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—kidney cancer	3.63e-06	4.49e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GSTM1—kidney cancer	3.62e-06	4.48e-05	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MAPK1—kidney cancer	3.61e-06	4.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.59e-06	4.44e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.59e-06	4.44e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—BRAF—kidney cancer	3.57e-06	4.42e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTT1—kidney cancer	3.57e-06	4.42e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ACHE—kidney cancer	3.57e-06	4.42e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.55e-06	4.4e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—kidney cancer	3.55e-06	4.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.54e-06	4.38e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTEN—kidney cancer	3.48e-06	4.31e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1A1—kidney cancer	3.43e-06	4.25e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTEN—kidney cancer	3.39e-06	4.2e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTEN—kidney cancer	3.39e-06	4.2e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—APRT—kidney cancer	3.38e-06	4.18e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FH—kidney cancer	3.38e-06	4.18e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SCARB1—kidney cancer	3.38e-06	4.18e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—kidney cancer	3.36e-06	4.16e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—POMC—kidney cancer	3.36e-06	4.16e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK3—kidney cancer	3.36e-06	4.15e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS1—kidney cancer	3.34e-06	4.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.3e-06	4.09e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PSMD7—kidney cancer	3.28e-06	4.06e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—POMC—kidney cancer	3.22e-06	3.99e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK1—kidney cancer	3.19e-06	3.95e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPC3—kidney cancer	3.18e-06	3.93e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—kidney cancer	3.17e-06	3.92e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—kidney cancer	3.17e-06	3.92e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACY1—kidney cancer	3.15e-06	3.9e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—BCHE—kidney cancer	3.11e-06	3.85e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CA2—kidney cancer	3.09e-06	3.83e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—POMC—kidney cancer	3.09e-06	3.82e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC5A5—kidney cancer	3.07e-06	3.8e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—POMC—kidney cancer	3.03e-06	3.75e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—kidney cancer	3.02e-06	3.73e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALAD—kidney cancer	3.01e-06	3.73e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—RAF1—kidney cancer	2.98e-06	3.69e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC2A1—kidney cancer	2.97e-06	3.67e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—kidney cancer	2.95e-06	3.65e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.94e-06	3.64e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—kidney cancer	2.93e-06	3.63e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTOR—kidney cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CD4—kidney cancer	2.91e-06	3.6e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—kidney cancer	2.89e-06	3.57e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.87e-06	3.56e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.76e-06	3.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PGK1—kidney cancer	2.76e-06	3.41e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1B—kidney cancer	2.73e-06	3.38e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—POMC—kidney cancer	2.72e-06	3.36e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LDHB—kidney cancer	2.7e-06	3.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PDHB—kidney cancer	2.68e-06	3.32e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—kidney cancer	2.68e-06	3.32e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—POMC—kidney cancer	2.67e-06	3.31e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—CTNNB1—kidney cancer	2.58e-06	3.2e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—kidney cancer	2.57e-06	3.18e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—POMC—kidney cancer	2.56e-06	3.17e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CCBL1—kidney cancer	2.52e-06	3.12e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—kidney cancer	2.52e-06	3.11e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTP1—kidney cancer	2.47e-06	3.06e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—kidney cancer	2.46e-06	3.05e-05	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—kidney cancer	2.45e-06	3.04e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—kidney cancer	2.42e-06	2.99e-05	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—kidney cancer	2.39e-06	2.96e-05	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—kidney cancer	2.39e-06	2.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CA9—kidney cancer	2.34e-06	2.9e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ABCB1—kidney cancer	2.34e-06	2.9e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—kidney cancer	2.34e-06	2.89e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GSTM1—kidney cancer	2.27e-06	2.81e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—kidney cancer	2.24e-06	2.77e-05	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—kidney cancer	2.23e-06	2.76e-05	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—kidney cancer	2.23e-06	2.76e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.19e-06	2.71e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPAT—kidney cancer	2.19e-06	2.71e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—kidney cancer	2.17e-06	2.68e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A1—kidney cancer	2.15e-06	2.67e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK3—kidney cancer	2.15e-06	2.66e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—kidney cancer	2.15e-06	2.66e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—kidney cancer	2.11e-06	2.61e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—kidney cancer	2.09e-06	2.59e-05	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—kidney cancer	2.07e-06	2.56e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK1—kidney cancer	2.05e-06	2.53e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—kidney cancer	2.04e-06	2.53e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—APRT—kidney cancer	2.03e-06	2.52e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FH—kidney cancer	2.03e-06	2.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CRABP1—kidney cancer	1.99e-06	2.47e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—kidney cancer	1.93e-06	2.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPC3—kidney cancer	1.91e-06	2.37e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—kidney cancer	1.89e-06	2.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CA2—kidney cancer	1.86e-06	2.3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ITPR2—kidney cancer	1.85e-06	2.29e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALAD—kidney cancer	1.81e-06	2.24e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—kidney cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—kidney cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.77e-06	2.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.73e-06	2.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ACHE—kidney cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTT1—kidney cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PGK1—kidney cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—kidney cancer	1.65e-06	2.04e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LDHB—kidney cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—POMC—kidney cancer	1.61e-06	1.99e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SCARB1—kidney cancer	1.6e-06	1.98e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS1—kidney cancer	1.58e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—kidney cancer	1.58e-06	1.96e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PSMD7—kidney cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—kidney cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—kidney cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BCHE—kidney cancer	1.47e-06	1.82e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.45e-06	1.8e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CA9—kidney cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.4e-06	1.74e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.36e-06	1.69e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.65e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—kidney cancer	1.28e-06	1.59e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—kidney cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTP1—kidney cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—kidney cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCB1—kidney cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GSTM1—kidney cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTT1—kidney cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ACHE—kidney cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SCARB1—kidney cancer	9.62e-07	1.19e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS1—kidney cancer	9.52e-07	1.18e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PSMD7—kidney cancer	9.33e-07	1.16e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BCHE—kidney cancer	8.85e-07	1.1e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.74e-07	1.08e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.44e-07	1.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.38e-07	1.04e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—kidney cancer	7.88e-07	9.76e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—POMC—kidney cancer	7.61e-07	9.41e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTP1—kidney cancer	7.04e-07	8.71e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCB1—kidney cancer	6.67e-07	8.25e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GSTM1—kidney cancer	6.47e-07	8.01e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.13e-07	7.59e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—kidney cancer	6.07e-07	7.51e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—kidney cancer	5.29e-07	6.55e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—POMC—kidney cancer	4.57e-07	5.66e-06	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.73e-07	4.62e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—kidney cancer	3.65e-07	4.51e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—kidney cancer	3.18e-07	3.94e-06	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.24e-07	2.78e-06	CbGpPWpGaD
